Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Phaxiam Therapeutics S.A.

PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
From Phaxiam Therapeutics S.A.
Via GlobeNewswire
Tickers PHXM
PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market
From Phaxiam Therapeutics S.A.
Via GlobeNewswire
Tickers PHXM
PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024
From Phaxiam Therapeutics S.A.
Via GlobeNewswire
Tickers PHXM
PHAXIAM Provides Business and Financial Update for the Third Quarter of 2023
From Phaxiam Therapeutics S.A.
Via GlobeNewswire
Tickers PHXM
PHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections caused by Staphylococcus aureus
From Phaxiam Therapeutics S.A.
Via GlobeNewswire
Tickers PHXM
TP ICAP Midcap initiates coverage of PHAXIAM Therapeutics with a “Buy” recommendation
From Phaxiam Therapeutics S.A.
Via GlobeNewswire
Tickers PHXM
PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strains
From Phaxiam Therapeutics S.A.
Via GlobeNewswire
PHAXIAM Receives Compliance Notice from Nasdaq
From Phaxiam Therapeutics S.A.
Via GlobeNewswire
PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration
From Phaxiam Therapeutics S.A.
Via GlobeNewswire
PHAXIAM Provides Business and Financial Update For the First Half of 2023
From Phaxiam Therapeutics S.A.
Via GlobeNewswire
PHAXIAM Therapeutics extends its phage portfolio to Klebsiella pneumoniae, a new resistant and aggressive bacterial target
From Phaxiam Therapeutics S.A.
Via GlobeNewswire
PHAXIAM Therapeutics announces the completion of its reverse share split
From Phaxiam Therapeutics S.A.
Via GlobeNewswire
PHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferences
From Phaxiam Therapeutics S.A.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.